ArticleScientific reports2026
Bevacizumab enhances overall survival in newly diagnosed glioblastoma patients with high COX-2 expression.
Irfan Kesumayadi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it